Skip to content

Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Anatomic Lung Resection Versus Thoracotomy and Anatomic Lung Resection

Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Anatomic Lung Resection Versus Thoracotomy and Anatomic Lung Resection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00598000
Enrollment
216
Registered
2008-01-18
Start date
2005-02-28
Completion date
2015-04-30
Last updated
2015-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Quality of Life, Thoracotomy, Video-assisted Thoracic Surgery (VATS)

Keywords

Lung cancer, Quality of Life, VATS, thoracotomy, 05-006

Brief summary

The purpose of this study is to see if different types of surgery for lung cancer have different effects on quality of life and pain. What we learn from this study may help us find new ways to improve the quality of life of lung cancer patients who have surgery.

Interventions

BEHAVIORALquestionnaires

QOL Measures- The following measures will be administered at Pre-Op, First Post-Op Visit 4, 8, 12 months Post-Op. Brief Pain Inventory and daily analgesic log- enrollment, patients will fill out the BPI preoperatively, postoperative days 2 to 4, initial, 4-month, 8-month and 12-month postoperative visits.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with histologically confirmed or suspected clinical stage I non small cell lung cancer (including carcinoid tumors) based on standard staging (CT, PET, ± mediastinoscopy). * Patients offered a VATS anatomic lung resection or a standard, posterolateral thoracotomy and anatomic lung resection at MSKCC. * Patients cannot have had prior therapy, including surgery for the current lesion, systemic chemotherapy or external beam radiotherapy. * KPS ≥ 70. * Synchronous primaries within one lobe.

Exclusion criteria

* Patients who have already undergone the planned operation. * Patients who cannot tolerate segmentectomy or lobectomy. * Patients with locally advanced or metastatic disease found either preoperatively or at the time of operation. * Patients who are non- English speaking * Patients with multi-focal disease * Patients with con-current cancers * Patients with benign disease. * Patients who are unwilling or unable to return to Memorial Sloan-Kettering Cancer Center for postoperative follow-up for the first year following their operation.

Design outcomes

Primary

MeasureTime frame
Determine the postoperative change in QOL and level of pain in patients with clinical stage I NSCLC undergoing VATS anatomic lung resection and for patients with clinical stage I NSCLC undergoing thoracotomy and anatomic lung resectionconclusion of study

Secondary

MeasureTime frame
Compare early postoperative analgesic requirements between the VATS and thoracotomy groups.conclusion of study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026